We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+9.93%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$738M
AUM Growth
+$120M
Cap. Flow
+$95.8M
Cap. Flow %
12.99%
Top 10 Hldgs %
7.41%
Holding
762
New
161
Increased
251
Reduced
119
Closed
207

Top Buys

Rank Stock Value
1
STLA icon
Stellantis
STLA
+$4.86M
2
ETSY icon
Etsy
ETSY
+$4.15M
3
LBTYK icon
Liberty Global Class C
LBTYK
+$3.86M
4
FLEX icon
Flex
FLEX
+$3.78M
5
TRUP icon
Trupanion
TRUP
+$3.64M

Top Sells

Rank Stock Value
1
TTEK icon
Tetra Tech
TTEK
+$3.65M
2
PANW icon
Palo Alto Networks
PANW
+$3.61M
3
GLOB icon
Globant
GLOB
+$3.3M
4
MRSH
Marsh
MRSH
+$3.21M
5
COTY icon
Coty
COTY
+$3.04M

Sector Composition

Rank Sector Weight
1 Technology 21.13%
2 Healthcare 19.11%
3 Financials 14.66%
4 Industrials 13.65%
5 Consumer Discretionary 8.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACRS icon
501
Aclaris Therapeutics
ACRS
$715M
$201K 0.03%
+24,857
New +$315K
TBLA icon
502
Taboola.com
TBLA
$1.41B
$201K 0.03%
+73,888
New +$249K
GATO
503
DELISTED
Gatos Silver, Inc.
GATO
$200K 0.03%
30,618
+8,541
+39% +$41.1K
NBIS
504
Nebius Group N.V.
NBIS
$37.6B
$193K 0.03%
10,169
FDMT icon
505
4D Molecular Therapeutics
FDMT
$502M
$186K 0.03%
10,795
-10,007
-48% -$195K
CFB
506
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
$185K 0.03%
+17,618
New +$225K
IMVT icon
507
Immunovant
IMVT
$7.93B
$183K 0.02%
11,779
+90
+0.8% +$1.56K
IHS icon
508
IHS Holding
IHS
$2.78B
$180K 0.02%
20,581
OSCR icon
509
Oscar Health
OSCR
$9.22B
$178K 0.02%
27,292
-27,600
-50% -$113K
SANA icon
510
Sana Biotechnology
SANA
$882M
$171K 0.02%
52,412
-101,623
-66% -$406K
SEER icon
511
Seer Inc
SEER
$114M
$171K 0.02%
+44,335
New +$204K
RLMD icon
512
Relmada Therapeutics
RLMD
$540M
$157K 0.02%
+69,362
New +$239K
NECB icon
513
Northeast Community Bancorp
NECB
$373M
$156K 0.02%
+11,894
New +$178K
AFYA icon
514
Afya
AFYA
$1.35B
$154K 0.02%
13,793
-10,354
-43% -$136K
ZIMV
515
DELISTED
ZimVie
ZIMV
$151K 0.02%
20,915
-4,600
-18% -$39.2K
JELD icon
516
JELD-WEN Holding
JELD
$110M
$148K 0.02%
+11,689
New +$145K
GTX icon
517
Garrett Motion
GTX
$5.37B
$148K 0.02%
+19,308
New +$149K
ARCE
518
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
$144K 0.02%
13,175
-1,443
-10% -$18.6K
ALHC icon
519
Alignment Healthcare
ALHC
$3.78B
$144K 0.02%
22,686
-55,015
-71% -$525K
BLFY
520
DELISTED
Blue Foundry Bancorp
BLFY
$143K 0.02%
+15,044
New +$173K
AMWL icon
521
American Well
AMWL
$180M
$141K 0.02%
2,988
SGHT icon
522
Sight Sciences
SGHT
$291M
$140K 0.02%
15,971
+1,786
+13% +$19.8K
VTEX icon
523
VTEX
VTEX
$767M
$132K 0.02%
34,489
GBIO
524
DELISTED
Generation Bio
GBIO
$132K 0.02%
3,067
+1,611
+111% +$77.9K
EWTX icon
525
Edgewise Therapeutics
EWTX
$4.28B
$129K 0.02%
19,343
+108
+0.6% +$1K

Similar funds

PDT Partners's Q1 2023 Portfolio in Review

As of Q1 2023, PDT Partners held 762 positions worth $738M, up 19% from $618M the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.

PDT Partners deployed $95.8M of net new capital in Q1 2023, opening 161 new positions and adding to 251 existing holdings. Its largest new stake was Etsy: 33,487 shares worth $3.73M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Coty, an estimated $3.04M trimmed.

  • PDT Partners's largest Q1 2023 buy was Etsy: 33,487 shares worth $3.73M.
  • PDT Partners added most to Stellantis in Q1 2023, an estimated $4.86M increase.
  • PDT Partners's biggest Q1 2023 reduction was Coty, cutting an estimated $3.04M.
  • PDT Partners fully exited Tetra Tech in Q1 2023, selling an estimated $3.65M.
  • PDT Partners's ten largest holdings make up 7.4% of its $738M portfolio in Q1 2023.
  • PDT Partners opened 161 new positions and closed 207 in Q1 2023.
  • PDT Partners's portfolio value rose 19% quarter-over-quarter to $738M.

Based on PDT Partners's 13F filing for Q1 2023, filed 15 May 2023.